CLINICAL_TRIALS
trial_result
· 2015-09-18
Clinical Trial Update: A Study of Pertuzumab in Participants With Prostate Cancer [Phase 2]
Summary
Phase 2 trial of pertuzumab in prostate cancer was terminated; results were posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hoffmann-La Roche | Conditions: Prostate Cancer | Phase 2 | Status: TERMINATED | Results posted: 2015-09-18